Featured Image of Top News Story: Some patients take 2nd at-home fecal test to delay colonoscopy

Some patients take 2nd at-home fecal test to delay colonoscopy

A study of 316,443 patients shows that 7.4% of patients repeated fecal testing rather than proceeding directly to colonoscopy as guidelines recommend, and of those who repeated home tests, over half did not have a colonoscopy within one year. Colorectal cancer is the second most common cancer-related ...

  • Clinical research center opens at Los Angeles Medical Center

    May 31, 2022
    A new dedicated clinical research space at the Kaiser Permanente Los Angeles Medical Center provides researchers and staff with expanded opportunities to bring groundbreaking clinical research to Kaiser Permanente Southern California members. Located on the first floor of 1505 N. Edgemont on the medical center campus, the 1,400-square-foot Kaiser Permanente Clinical Research Center at Los Angeles ...
    Read more...
  • 5 questions for … Dr. William Towner

    May 19, 2022
    William Towner, MD, FACP, FIDSA, is the regional physician director for the Division of Clinical Trials and leads the Clinician Investigator Program for the Southern California Permanente Medical Group. He also serves in a leadership role for HIV services at Kaiser Permanente Southern California. He was extensively involved in research on infectious diseases since 2000 ...
    Read more...
  • COVID-19 vaccine protection against hospitalization wanes for the most vulnerable

    April 25, 2022
    Research released in The Lancet Respiratory Medicine shows that a booster dose of the Pfizer COVID-19 vaccine provides strong protection, roughly 80% in the first few months against hospital admissions and emergency department visits caused by the delta and omicron variants. However, against omicron, this protection wanes over time for immunocompromised individuals — even after ...
    Read more...
  • Heart attacks increased in days after 2020 election

    April 20, 2022
    A Kaiser Permanente study conducted in Southern and Northern California found hospitalizations for heart attack, stroke, and heart failure were 17% higher in the 5 days after the 2020 election than in the same 5 days 2 weeks before the election. The study was published April 20, 2022, in JAMA Network Open. “This study of the ...
    Read more...
  • Five questions for … Dr. “Charlie” Huang

    March 25, 2022
    Cheng-Wei “Charlie” Huang, MD, is a hospitalist at the Kaiser Permanente Los Angeles Medical Center who has spent recent years also focused on research that can improve care for patients. In addition to his research and clinical duties, Dr. Huang is the assistant program director of the  Los Angeles Medical Center’s internal medicine residency, where ...
    Read more...
  • Shoulder pain rare after vaccination

    March 21, 2022
    Shoulder pain and injury are extremely rare after any type of vaccination in the upper arm, according to pre-pandemic Kaiser Permanente research published March 22, 2022, in Annals of Internal Medicine. Conducted from April 2016 through December 2017, the study found fewer than 1 in 10,000 people reported shoulder injuries in the more than 2.2 million ...
    Read more...
  • 3 doses of Moderna COVID-19 vaccine highly effective against hospitalization from omicron or delta.

    February 21, 2022
    Kaiser Permanente research published Feb. 21, 2022, in Nature Medicine shows that while Moderna COVID-19 vaccine protection is strong against coronavirus infection by the delta variant, it is not as strong against infection from the omicron variant. Three doses of the Moderna COVID-19 vaccine were highly effective against hospitalization caused by infection from either the omicron ...
    Read more...
  • Vaccine study looks to prevent E. coli sepsis

    February 21, 2022
    Kaiser Permanente Southern California is participating in a clinical trial of a novel vaccine against invasive E. coli infections in older adults. William Towner, MD, the principal investigator for Kaiser Permanente Southern California, said, “I’m enthusiastic about this cutting-edge research because it has the potential, if successful, to reduce morbidity and mortality from a very common ...
    Read more...
  • 3 doses of Pfizer–BioNTech COVID vaccine better than 2

    February 14, 2022
    A Kaiser Permanente study published February 14, 2022, in The Lancet Regional Health – Americas found that 1 month after a third dose, the Pfizer-BioNTech COVID-19 vaccine effectiveness is higher for preventing infection and hospitalization than 2 doses of the vaccine after 1 month. “When we looked at the effectiveness of the 2 doses of Pfizer–BioNTech ...
    Read more...
  • Five questions for … Dr. Amandeep Sahota

    January 31, 2022
    Amandeep Sahota, MD, directs the Department of Hepatology at the Kaiser Permanente Los Angeles Medical Center. She is also assistant medical director of Transplant Services for Kaiser Permanente Southern California. In this role, she promotes clinical quality programs, implementation of virtual medicine, and data analytics on chronic diseases outcomes. Her efforts have improved patient access ...
    Read more...